The impact of demographics on the prevalence and treatment of type 2 diabetes - a literature review
DOI:
https://doi.org/10.12775/JEHS.2025.86.67335Keywords
diabetes, type 2 diabetes, personalized therapy, demographicsAbstract
Background Type 2 Diabetes is, without a doubt, a global health crisis. Detailed guidelines have been made to create a universal standard for prevention, screening, and therapy, but far too often, a single model proves inefficient in treating patients from all walks of life, displaying a wide variance in both clinical and lifestyle factors.
Aim This review of the existing literature attempts to showcase the main differences in the prevalence, risk factors, and therapy effectiveness of Type 2 Diabetes between a number of demographics.
Materials and Methods The article thoroughly reviews the existing literature on Type 2 Diabetes and the demographic factors thereof. Original studies, reviews, meta-analyses, as well as epidemiological surveys available in the PubMed and Google Scholar databases were included. The literature review and article selection process concluded in November 2025.
Results The available data backs up the hypothesis that demographic factors heavily influence the prevalence and outcomes of Type 2 Diabetes. The illness is both more prevalent and on average, more poorly controlled in women, as compared to men, resulting in a higher all-cause mortality. In terms of age, each additional year at the time of diagnosis correlates with a 4% decrease in all-cause mortality, as well as a 3% decrease in macrovascular and 5% decrease in microvascular complications. Additionally, socioeconomic factors have been found to play a significant role in therapy adherence, even in countries with a well-developed social safety net.
Conclusions The findings showcase a desperate need for a more personalized approach to Type 2 Diabetes, focusing on the elimination of negative lifestyle habits, a thorough patient education, and a choice of medication that is within an acceptable financial range, rather than simply prescribing that, which displays the highest effectiveness on paper.
References
1. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020 Mar;10(1):107-111. doi: 10.2991/jegh.k.191028.001. PMID: 32175717; PMCID: PMC7310804.
2. Guzman-Vilca WC, Carrillo-Larco RM. Number of People with Type 2 Diabetes Mellitus in 2035 and 2050: A Modelling Study in 188 Countries. Curr Diabetes Rev. 2024;21(1):e120124225603. doi: 10.2174/0115733998274323231230131843. PMID: 38231048.
3. Shamanna P, Joshi S, Thajudeen M, Shah L, Poon T, Mohamed M, Mohammed J. Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic control. Front Endocrinol (Lausanne). 2024 Nov 20;15:1485464. doi: 10.3389/fendo.2024.1485464. PMID: 39634180; PMCID: PMC11615876.
4. Goyal Mehra, C., Raymond, A.M. & Prabhu, R. A personalized multi-interventional approach focusing on customized nutrition, progressive fitness, and lifestyle modification resulted in the reduction of HbA1c, fasting blood sugar and weight in type 2 diabetes: a retrospective study. BMC Endocr Disord 22, 290 (2022). https://doi.org/10.1186/s12902-022-01212-2
5. Dennis JM. Precision Medicine in Type 2 Diabetes: Using Individualized Prediction Models to Optimize Selection of Treatment. Diabetes. 2020 Oct;69(10):2075-2085. doi: 10.2337/dbi20-0002. Epub 2020 Aug 25. PMID: 32843566; PMCID: PMC7506836.
6. Pan C, Cao B, Fang H, Liu Y, Zhang S, Luo W, Wu Y. Global burden of diabetes mellitus 1990-2021: epidemiological trends, geospatial disparities, and risk factor dynamics. Front Endocrinol (Lausanne). 2025 Jul 1;16:1596127. doi: 10.3389/fendo.2025.1596127. PMID: 40666058; PMCID: PMC12259457.
7. Kautzky-Willer A, Leutner M, Harreiter J. Sex differences in type 2 diabetes. Diabetologia. 2023 Jun;66(6):986-1002. doi: 10.1007/s00125-023-05891-x. Epub 2023 Mar 10. Erratum in: Diabetologia. 2023 Jun;66(6):1165. doi: 10.1007/s00125-023-05913-8. PMID: 36897358; PMCID: PMC10163139.
8. Alexandra Kautzky-Willer, Jürgen Harreiter, Giovanni Pacini, Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus, Endocrine Reviews, Volume 37, Issue 3, 1 June 2016, Pages 278–316, https://doi.org/10.1210/er.2015-1137
9. Choe SA, Kim JY, Ro YS, Cho SI. Women are less likely than men to achieve optimal glycemic control after 1 year of treatment: A multi-level analysis of a Korean primary care cohort. PLoS One. 2018 May 2;13(5):e0196719. doi: 10.1371/journal.pone.0196719. PMID: 29718952; PMCID: PMC5931663.
10. Diaz-Santana MV, O'Brien KM, Park YM, Sandler DP, Weinberg CR. Persistence of Risk for Type 2 Diabetes After Gestational Diabetes Mellitus. Diabetes Care. 2022 Apr 1;45(4):864-870. doi: 10.2337/dc21-1430. PMID: 35104325; PMCID: PMC9016728.
11. Chivese T, Norris SA, Levitt NS (2019) Progression to type 2 diabetes mellitus and associated risk factors after hyperglycemia first detected in pregnancy: A cross-sectional study in Cape Town, South Africa. PLOS Medicine 16(9): e1002865. https://doi.org/10.1371/journal.pmed.1002865
12. Andrea Cremaschi, Willem van den Boom, Nicholas Beng Hui Ng, Beatrice Franzolini, Kelvin B. Tan, Jerry Kok Yen Chan, Kok Hian Tan, Yap-Seng Chong, Johan G. Eriksson, Maria De Iorio, Postpartum Screening for Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus: A Cost-Effectiveness Analysis in Singapore, Value in Health Regional Issues, Volume 45, 2025, 101048, ISSN 2212-1099, https://doi.org/10.1016/j.vhri.2024.101048.
13. Bentley-Lewis R, Levkoff S, Stuebe A, Seely EW. Gestational diabetes mellitus: postpartum opportunities for the diagnosis and prevention of type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2008 Oct;4(10):552-8. doi: 10.1038/ncpendmet0965. Epub 2008 Sep 9. PMID: 18779843; PMCID: PMC4428574.
14. Xu G, You D, Wong L, Duan D, Kong F, Zhang X, Zhao J, Xing W, Han L, Li L. Risk of all-cause and CHD mortality in women versus men with type 2 diabetes: a systematic review and meta-analysis. Eur J Endocrinol. 2019 Apr;180(4):243-255. doi: 10.1530/EJE-18-0792. PMID: 30668524; PMCID: PMC6391911.
15. Singh SS, Roeters-van Lennep JE, Lemmers RFH, van Herpt TTW, Lieverse AG, Sijbrands EJG, van Hoek M. Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study. Acta Diabetol. 2020 Jun;57(6):725-732. doi: 10.1007/s00592-020-01489-6. Epub 2020 Feb 5. PMID: 32025877; PMCID: PMC7220974.
16. Wang, Y., O’Neil, A., Jiao, Y. et al. Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants. BMC Med 17, 136 (2019). https://doi.org/10.1186/s12916-019-1355-0
17. Ng R, Sutradhar R, Yao Z, Wodchis WP, Rosella LC. Smoking, drinking, diet and physical activity-modifiable lifestyle risk factors and their associations with age to first chronic disease. Int J Epidemiol. 2020 Feb 1;49(1):113-130. doi: 10.1093/ije/dyz078. PMID: 31329872; PMCID: PMC7124486.
18. Nanayakkara, N., Curtis, A.J., Heritier, S. et al. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia 64, 275–287 (2021). https://doi.org/10.1007/s00125-020-05319-w
19. Natalie Nanayakkara, Sanjeeva Ranasinha, Adelle Gadowski, Stephane Heritier, Jeff R. Flack, Natalie Wischer, Jencia Wong, Sophia Zoungas, Age, age at diagnosis and diabetes duration are all associated with vascular complications in type 2 diabetes, Journal of Diabetes and its Complications, Volume 32, Issue 3, 2018, Pages 279-290, ISSN 1056-8727, https://doi.org/10.1016/j.jdiacomp.2017.11.009.
20. Quah JH, Liu YP, Luo N, How CH, Tay EG. Younger adult type 2 diabetic patients have poorer glycaemic control: a cross-sectional study in a primary care setting in Singapore. BMC Endocr Disord. 2013 Jun 3;13:18. doi: 10.1186/1472-6823-13-18. PMID: 23725198; PMCID: PMC3674913.
21. Nanayakkara N, Pease AJ, Ranasinha S, Wischer N, Andrikopoulos S, de Courten B, Zoungas S. Younger people with Type 2 diabetes have poorer self-care practices compared with older people: results from the Australian National Diabetes Audit. Diabet Med. 2018 Aug;35(8):1087-1095. doi: 10.1111/dme.13660. Epub 2018 Jun 1. PMID: 29729055.
22. Bonikowska I, Szwamel K, Uchmanowicz I. Adherence to Medication in Older Adults with Type 2 Diabetes Living in Lubuskie Voivodeship in Poland: Association with Frailty Syndrome. J Clin Med. 2022 Mar 19;11(6):1707. doi: 10.3390/jcm11061707. PMID: 35330032; PMCID: PMC8953376.
23. Kim SH, Lee SY, Kim CW, Suh YJ, Hong S, Ahn SH, Seo DH, Nam MS, Chon S, Woo JT, Baik SH, Park Y, Lee KW, Kim YS; KNDP Study Group. Impact of Socioeconomic Status on Health Behaviors, Metabolic Control, and Chronic Complications in Type 2 Diabetes Mellitus. Diabetes Metab J. 2018 Oct;42(5):380-393. doi: 10.4093/dmj.2017.0102. Epub 2018 Jun 29. PMID: 30113143; PMCID: PMC6202566.
24. Ekenberg, M., Qvarnström, M., Sundström, A. et al. Socioeconomic factors associated with poor medication adherence in patients with type 2 diabetes. Eur J Clin Pharmacol 80, 53–63 (2024). https://doi.org/10.1007/s00228-023-03571-8
25. Vaughan EM, Rueda JJ, Samson SL, Hyman DJ. Reducing the Burden of Diabetes Treatment: A Review of Low-cost Oral Hypoglycemic Medications. Curr Diabetes Rev. 2020;16(8):851-858. doi: 10.2174/1573399816666200206112318. PMID: 32026779; PMCID: PMC7415714.
26. Ho, C.M., Yeh, T.H., Lai, Y.T. PDB16 Cost-Effectiveness of ADD-on Therapies to Metformin: The IMPACT of Medication Adherence for Type 2 Diabetes Mellitus Value in Health, Volume 24, S80 2021/06/01, 2021, doi: 10.1016/j.jval.2021.04.414
27. Pham TM, Carpenter JR, Morris TP, Sharma M, Petersen I. Ethnic Differences in the Prevalence of Type 2 Diabetes Diagnoses in the UK: Cross-Sectional Analysis of the Health Improvement Network Primary Care Database. Clin Epidemiol. 2019 Dec 31;11:1081-1088. doi: 10.2147/CLEP.S227621. PMID: 32021464; PMCID: PMC6948201.
28. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care. 1999 Mar;22(3):403-8. doi: 10.2337/diacare.22.3.403. PMID: 10097918.
29. Smalls BL, Ritchwood TD, Bishu KG, Egede LE. Racial/Ethnic Differences in Glycemic Control in Older Adults with Type 2 Diabetes: United States 2003-2014. Int J Environ Res Public Health. 2020 Feb 4;17(3):950. doi: 10.3390/ijerph17030950. PMID: 32033032; PMCID: PMC7036954.
30. Iglay K, Hannachi H, Joseph Howie P, Xu J, Li X, Engel SS, Moore LM, Rajpathak S. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016 Jul;32(7):1243-52. doi: 10.1185/03007995.2016.1168291. Epub 2016 Apr 4. PMID: 26986190.
31. Adriaanse, M.C., Drewes, H.W., van der Heide, I. et al. The impact of comorbid chronic conditions on quality of life in type 2 diabetes patients. Qual Life Res 25, 175–182 (2016). https://doi.org/10.1007/s11136-015-1061-0
32. El-Kebbi IM, Ziemer DC, Cook CB, Miller CD, Gallina DL, Phillips LS. Comorbidity and glycemic control in patients with type 2 diabetes. Arch Intern Med. 2001 May 28;161(10):1295-300. doi: 10.1001/archinte.161.10.1295. PMID: 11371257.
33. Luijks H, Biermans M, Bor H, van Weel C, Lagro-Janssen T, de Grauw W, Schermer T. The Effect of Comorbidity on Glycemic Control and Systolic Blood Pressure in Type 2 Diabetes: A Cohort Study with 5 Year Follow-Up in Primary Care. PLoS One. 2015 Oct 1;10(10):e0138662. doi: 10.1371/journal.pone.0138662. PMID: 26426904; PMCID: PMC4591264
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Patryk Gadziński, Marta Czechowicz, Joanna Madoń

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 9
Number of citations: 0